In this study patients receiving lubiprostone were nearlytwice as l...IBS is a condition that affects approximately 58 millionAmericans and...Lubiprostone is a novel selective chloride channel activatorthat has ... <a href="http://www.bio-medicine.org/inc/biomed/medicine-technology.asp">http://www.bio-medicine.org/inc/biomed/medicine-technology.asp</a> http://feeds.bio-medicine.org/latest-medical-technology WASHINGTON, May 21, 2007 /PRNewswire/ -- A new study